RT Journal Article SR Electronic T1 Characterization of the Histamine H2 Receptor Structural Components Involved in Dual Signaling JF Journal of Pharmacology and Experimental Therapeutics JO J Pharmacol Exp Ther FD American Society for Pharmacology and Experimental Therapeutics SP 573 OP 578 VO 285 IS 2 A1 L-D. Wang A1 M. Hoeltzel A1 I. Gantz A1 R. Hunter A1 J. Del Valle YR 1998 UL http://jpet.aspetjournals.org/content/285/2/573.abstract AB We previously demonstrated that the histamine H2 receptor can activate both adenylate cyclase (AC) and phospholipase C (PLC) signaling pathways via separate GTP- dependent mechanisms. We examined whether H2 receptor-specific peptides corresponding to the amino (N) or carboxyl terminus (C) of the second (2i) or third (3i) intracytoplasmic loops or the carboxyl terminal tail (P4iN) could effect histamine- stimulated AC and PLC activity in cell membranes prepared from HEPA cells stably transfected to express the canine H2 histamine receptor cDNA. Tiotidine binding and basal signaling were not altered by the synthetic peptides. H2P2iN, H2P2iC, H2P3iN and H2P4iN did not effect histamine stimulated AC activity although H2P3iC (10−4 M) significantly inhibited this parameter (65.6 ± 7.2% of maximal stimulation) (n = 6). Combination of the five peptides (H2P2iN, H2P2iC, H2P3iN, H2P3iC and H2P4iN) abolished histamine stimulated AC activity. Although all of the peptides inhibited histamine-stimulated PLC activity to a moderate degree individually, H2P3iC (10−4 M) had the greatest effect, decreasing PLC activation to 20.8 ± 6.3% of maximal stimulation (IC50 = 7.5 × 10−7 M) (n = 6). H2P3iC and the peptide combination did not alter, forskolin, GTPγs or epinephrine-stimulated AC activity nor GTPγs and vasopressin-stimulated PLC. These studies demonstrate that both the second and third intracytoplasmic loops of the histamine H2 receptor are linked to separate signaling pathways in a differential manner. The American Society for Pharmacology and Experimental Therapeutics